ATE473214T1 - 2-(4-oxo-4h-chinazolin-3-yl)acetamide und ihre verwendung als vasopressin-v3-antagonisten - Google Patents
2-(4-oxo-4h-chinazolin-3-yl)acetamide und ihre verwendung als vasopressin-v3-antagonistenInfo
- Publication number
- ATE473214T1 ATE473214T1 AT06725007T AT06725007T ATE473214T1 AT E473214 T1 ATE473214 T1 AT E473214T1 AT 06725007 T AT06725007 T AT 06725007T AT 06725007 T AT06725007 T AT 06725007T AT E473214 T1 ATE473214 T1 AT E473214T1
- Authority
- AT
- Austria
- Prior art keywords
- chinazoline
- vasopressin
- acetamide
- antagonists
- oxo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66092605P | 2005-03-11 | 2005-03-11 | |
| US71587505P | 2005-09-09 | 2005-09-09 | |
| PCT/EP2006/060612 WO2006095014A1 (en) | 2005-03-11 | 2006-03-10 | 2- (4-0x0-4h-quinaz0lin-3-yl) acetamides and their use as vasopressin v3 antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE473214T1 true ATE473214T1 (de) | 2010-07-15 |
Family
ID=36579595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06725007T ATE473214T1 (de) | 2005-03-11 | 2006-03-10 | 2-(4-oxo-4h-chinazolin-3-yl)acetamide und ihre verwendung als vasopressin-v3-antagonisten |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7807686B2 (de) |
| EP (1) | EP1861380B1 (de) |
| JP (1) | JP4997391B2 (de) |
| KR (1) | KR20080009076A (de) |
| AR (1) | AR052943A1 (de) |
| AT (1) | ATE473214T1 (de) |
| AU (1) | AU2006221962A1 (de) |
| CA (1) | CA2599511C (de) |
| DE (1) | DE602006015293D1 (de) |
| ES (1) | ES2346790T3 (de) |
| IL (1) | IL185343A0 (de) |
| MX (1) | MX2007011023A (de) |
| NO (1) | NO20074275L (de) |
| NZ (1) | NZ560958A (de) |
| PE (1) | PE20061106A1 (de) |
| RU (1) | RU2007137649A (de) |
| TW (1) | TW200643015A (de) |
| WO (1) | WO2006095014A1 (de) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200643015A (en) | 2005-03-11 | 2006-12-16 | Akzo Nobel Nv | 2-(4-oxo-4H-quinazolin-3-yl)acetamide derivatives |
| CN101600698B (zh) | 2006-09-11 | 2012-01-11 | 欧加农股份有限公司;药典有限责任公司 | 喹唑啉酮和异喹啉酮乙酰胺衍生物 |
| ATE523493T1 (de) | 2006-09-11 | 2011-09-15 | Organon Nv | 2-(1-oxo-1h-isochinolin-2-yl) acetamid-derivate |
| US20100179176A1 (en) * | 2006-12-13 | 2010-07-15 | N.V. Organon | V3 antagonists for the treatment or prevention of chronic pain |
| JP2010229035A (ja) * | 2007-08-01 | 2010-10-14 | Taisho Pharmaceutical Co Ltd | ピリドピリミジン−４−オン誘導体 |
| JP5369721B2 (ja) * | 2009-01-30 | 2013-12-18 | 大正製薬株式会社 | ピリドピリミジン−４−オン誘導体 |
| PT2464645T (pt) | 2009-07-27 | 2017-10-11 | Gilead Sciences Inc | Compostos heterocíclicos fusionados como moduladores do canal de iões |
| WO2011091407A1 (en) * | 2010-01-25 | 2011-07-28 | Glaxosmithkline Llp | Trpv4 antagonists |
| WO2012003392A1 (en) | 2010-07-02 | 2012-01-05 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
| LT2621894T (lt) * | 2010-09-27 | 2017-01-25 | E. I. Du Pont De Nemours And Company | 2-amino-n-(2,2,2-trifluoretil)acetamido gavimo būdas |
| ME02169B (me) * | 2010-10-01 | 2015-10-20 | Taisho Pharmaceutical Co Ltd | Derivat 1,2,4-triazolona |
| AU2012253653A1 (en) * | 2011-05-10 | 2013-05-02 | Gilead Sciences, Inc. | Fused heterocyclic compounds as sodium channel modulators |
| TWI622583B (zh) | 2011-07-01 | 2018-05-01 | 基利科學股份有限公司 | 作為離子通道調節劑之稠合雜環化合物 |
| NO3175985T3 (de) | 2011-07-01 | 2018-04-28 | ||
| CN103889951B (zh) | 2011-10-27 | 2016-12-14 | 大正制药株式会社 | 唑类衍生物 |
| HK1200829A1 (en) | 2012-03-30 | 2015-08-14 | 大正制药株式会社 | Fused azole derivative |
| CA2872883A1 (en) * | 2012-05-09 | 2013-11-14 | Sunovion Pharmaceuticals Inc. | Heteroaryl compounds and methods of use thereof |
| US9227978B2 (en) | 2013-03-15 | 2016-01-05 | Araxes Pharma Llc | Covalent inhibitors of Kras G12C |
| JO3805B1 (ar) | 2013-10-10 | 2021-01-31 | Araxes Pharma Llc | مثبطات كراس جي12سي |
| EP3191459A1 (de) | 2014-09-05 | 2017-07-19 | AbbVie Deutschland GmbH & Co. KG | Kondensierte heterocyclischen oder carbocyclischen verbindungen mit substituierten cycloaliphatischen rest und verwendung zur behandlung von vasopressin-erkrankungen |
| WO2017015562A1 (en) * | 2015-07-22 | 2017-01-26 | Araxes Pharma Llc | Substituted quinazoline compounds and their use as inhibitors of g12c mutant kras, hras and/or nras proteins |
| EP3356349A1 (de) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibitoren von kras-g12c-mutanten proteinen |
| EP3377481A1 (de) | 2015-11-16 | 2018-09-26 | Araxes Pharma LLC | 2-substituierte chinazolinverbindungen mit einer substituierten heterocyclischen gruppe und verfahren zur verwendung davon |
| ES2821010T3 (es) | 2015-12-09 | 2021-04-23 | Cadent Therapeutics Inc | Moduladores heteroaromáticos del receptor NMDA y usos de los mismos |
| US10500205B2 (en) | 2015-12-09 | 2019-12-10 | Cadent Therapeutics, Inc. | Thienopyrimidinone NMDA receptor modulators and uses thereof |
| CA3047403A1 (en) | 2016-12-22 | 2018-06-28 | Cadent Therapeutics, Inc. | Nmda receptor modulators and uses thereof |
| WO2018140513A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | 1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-one derivatives and similar compounds as kras g12c modulators for treating cancer |
| EP3573954A1 (de) | 2017-01-26 | 2019-12-04 | Araxes Pharma LLC | Fusionierte bicyclische benzoheteroaromatische verbindungen und verfahren zur verwendung davon |
| CN110382482A (zh) | 2017-01-26 | 2019-10-25 | 亚瑞克西斯制药公司 | 稠合的杂-杂二环化合物及其使用方法 |
| US11136308B2 (en) | 2017-01-26 | 2021-10-05 | Araxes Pharma Llc | Substituted quinazoline and quinazolinone compounds and methods of use thereof |
| US11358959B2 (en) | 2017-01-26 | 2022-06-14 | Araxes Pharma Llc | Benzothiophene and benzothiazole compounds and methods of use thereof |
| CN110869358A (zh) | 2017-05-25 | 2020-03-06 | 亚瑞克西斯制药公司 | Kras的共价抑制剂 |
| CN110831933A (zh) | 2017-05-25 | 2020-02-21 | 亚瑞克西斯制药公司 | 喹唑啉衍生物作为突变kras、hras或nras的调节剂 |
| BR112021001709A2 (pt) | 2018-08-01 | 2021-05-04 | Araxes Pharma Llc | compostos espiro heterocíclicos e métodos de uso dos mesmos para o tratamento de câncer |
| CA3108519A1 (en) | 2018-08-03 | 2020-04-30 | Cadent Therapeutics, Inc. | Heteroaromatic nmda receptor modulators and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2506767A1 (fr) | 1981-05-26 | 1982-12-03 | Synthelabo | Derives heterocycliques d'amidoximes, leur preparation et leur application en therapeutique |
| FR2804114B1 (fr) | 2000-01-25 | 2002-03-08 | Sanofi Synthelabo | Nouveaux derives de 1,3-dihydro-2h-indol-2-one, un procede pour leur preparation et les compositions pharmaceutiques en contenant |
| FR2842527B1 (fr) | 2002-07-19 | 2005-01-28 | Sanofi Synthelabo | Derives d'acyloxypyrolidine, leur preparation et leur application en therapeutique |
| TW200643015A (en) | 2005-03-11 | 2006-12-16 | Akzo Nobel Nv | 2-(4-oxo-4H-quinazolin-3-yl)acetamide derivatives |
-
2006
- 2006-03-02 TW TW095107055A patent/TW200643015A/zh unknown
- 2006-03-09 PE PE2006000270A patent/PE20061106A1/es not_active Application Discontinuation
- 2006-03-10 NZ NZ560958A patent/NZ560958A/en not_active IP Right Cessation
- 2006-03-10 WO PCT/EP2006/060612 patent/WO2006095014A1/en not_active Ceased
- 2006-03-10 ES ES06725007T patent/ES2346790T3/es not_active Expired - Lifetime
- 2006-03-10 EP EP06725007A patent/EP1861380B1/de not_active Expired - Lifetime
- 2006-03-10 JP JP2008500206A patent/JP4997391B2/ja not_active Expired - Lifetime
- 2006-03-10 CA CA2599511A patent/CA2599511C/en not_active Expired - Fee Related
- 2006-03-10 RU RU2007137649/04A patent/RU2007137649A/ru not_active Application Discontinuation
- 2006-03-10 DE DE602006015293T patent/DE602006015293D1/de not_active Expired - Lifetime
- 2006-03-10 AR ARP060100908A patent/AR052943A1/es unknown
- 2006-03-10 KR KR1020077023214A patent/KR20080009076A/ko not_active Withdrawn
- 2006-03-10 MX MX2007011023A patent/MX2007011023A/es active IP Right Grant
- 2006-03-10 US US11/908,221 patent/US7807686B2/en not_active Expired - Lifetime
- 2006-03-10 AT AT06725007T patent/ATE473214T1/de not_active IP Right Cessation
- 2006-03-10 AU AU2006221962A patent/AU2006221962A1/en not_active Abandoned
-
2007
- 2007-08-16 IL IL185343A patent/IL185343A0/en unknown
- 2007-08-22 NO NO20074275A patent/NO20074275L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006221962A1 (en) | 2006-09-14 |
| IL185343A0 (en) | 2008-02-09 |
| MX2007011023A (es) | 2008-03-12 |
| WO2006095014A1 (en) | 2006-09-14 |
| EP1861380B1 (de) | 2010-07-07 |
| NZ560958A (en) | 2009-09-25 |
| AR052943A1 (es) | 2007-04-11 |
| PE20061106A1 (es) | 2006-10-13 |
| JP4997391B2 (ja) | 2012-08-08 |
| DE602006015293D1 (de) | 2010-08-19 |
| US7807686B2 (en) | 2010-10-05 |
| EP1861380A1 (de) | 2007-12-05 |
| TW200643015A (en) | 2006-12-16 |
| ES2346790T3 (es) | 2010-10-20 |
| JP2008532981A (ja) | 2008-08-21 |
| RU2007137649A (ru) | 2009-04-20 |
| CA2599511A1 (en) | 2006-09-14 |
| NO20074275L (no) | 2007-09-27 |
| KR20080009076A (ko) | 2008-01-24 |
| CA2599511C (en) | 2013-12-10 |
| US20080214553A1 (en) | 2008-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602006015293D1 (de) | 2-(4-oxo-4h-chinazolin-3-yl)acetamide und ihre verwendung als vasopressin-v3-antagonisten | |
| ATE520681T1 (de) | N-thioanthranilamidverbindungen und ihre verwendung als pestizide | |
| ATE370136T1 (de) | Benzimidazolderivate und ihre verwendung als antagonisten des a ii rezeptors | |
| ATE432975T1 (de) | Flüssigwaschmittel und ihre verwendung | |
| DE602007013869D1 (de) | Substituierte imidazole und ihre verwendung als pestizide | |
| ATE544758T1 (de) | Carboxamidverbindungen und ihre verwendung als calpain-hemmer | |
| ATE548355T1 (de) | 4- (4-cyano-2-thioaryl) -dihydropyrimidinone und ihre verwendung | |
| ATE543825T1 (de) | Spiro-oxindolverbindungen und ihre verwendungen als therapeutische mittel | |
| ATE440093T1 (de) | 1-alkinyl-2-aryloxyalkylamide und ihre verwendung als fungizide | |
| EP1746902A4 (de) | Multilektin-affiniätschromatografie und verwendung dafür | |
| ATE478059T1 (de) | Cinnamoylpiperazinderivate und ihre verwendung als par-1-antagonisten | |
| DE602005023639D1 (de) | Chinuclidinderivate und deren verwendung als muscarin-m3-rezeptor-antagonisten | |
| DE502005007106D1 (de) | Substituierte phenylaminothiazole und ihre verwendung | |
| ATE454377T1 (de) | 2-phenyl-6-aminocarbonylpyrimidinderivate und ihre verwendung als antagonisten am p2y12- rezeptor | |
| ATE538130T1 (de) | Pyrimidinderivate und ihre verwendung als p2y12- rezeptorantagonisten | |
| ATE417045T1 (de) | Substituierte diazaspiroä5.5üundecanderivate und deren verwendung als neurokininantagonisten | |
| ATE513817T1 (de) | Pyrimidinderivate und ihre verwendung als pestizide | |
| EP2143709A4 (de) | Amidverbindung und ihre verwendung | |
| ATE511507T1 (de) | Piperidinylcarbonylpyrrolidine und deren verwendung als melanocortinagonisten | |
| ATE486070T1 (de) | Piperidinylaminopyridazine und ihre verwendung als schnelldissoziierende antagonisten des dopamin-2-rezeptors | |
| ATE445612T1 (de) | Piperidin-4-yl-amidderivate und ihre verwendung als antagonisten des sst-rezeptors vom subtyp 5 | |
| ATE429428T1 (de) | Indanderivate als antagonisten des mch-rezeptors | |
| ATE442366T1 (de) | Oxazolidinonderivate und ihre verwendung als antibiotika | |
| DE502005002170D1 (de) | Amphiphile polymerzusammensetzungen und ihre verwendung | |
| DE602006009296D1 (de) | Oligopeptide und ihre verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |